Understanding Tardive Dyskinesia to Make a Difference

MAY 5, 2026 • 7pm eastern

Kendra Davies, BS Pharmacy, PharmD, RPh

Don’t miss this special edition webinar presented by Neurocrine Biosciences!
A Look at the Impact, Identification, and Treatment of Tardive Dyskinesia. Understanding the need to screen for TD at every clinical encounter, and building confidence in assessing TD through the AIMS scale, are essential steps toward improving patient care. The Abnormal Involuntary Movement Scale (AIMS) serves as a reliable compass. With practice, it becomes less of a checklist and more of a clinical rhythm, guiding observation of facial, oral, extremity, and trunk movements while grounding decisions in consistency and objectivity. Timely recognition opens the door to meaningful intervention, including medication adjustments and targeted treatments.

Every THIRD Tuesday* of the month the AADMD Student & Resident Committee hosts interdisciplinary webinars for clinicians to learn from colleagues in a patient-centered manner with the purpose of encouraging comprehensive care provision to patients with IDD.

*Day of the week is subject to change.